Breasts! They're back! Say goodbye to insanely inflated neck-choking plumpers and get used to the real thing. On Wednesday, Allergan, the makers of Botox and breast implants, reported the company's quarterly overall sales down 3% from last year. While Allergan does most of its business in eyecare (they recently discovered their glaucoma drug also helps create longer "wolf eyes" lashes), vanity products saw a significant sales drop from the same time last year. Botox fell 3%, skin-plumping injections withered almost 9%, and breast implants collapsed 12%.

"Wrinkled faces may be the latest example of recession chic," reports the New York Times. A poll among dermatologists and plastic surgeons revealed procedures are down 20% to 50%. Meanwhile, Allergan's prexy is doing his part to keep spirits buoyant, encouraging consumers with $50 Botox coupons and $100 rebates for Juvederm facial fillers. D-cups are still going to cost you a stack of C-notes, though.